Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value ($000): $1,665,451 (100.0% shares, 0.0% debt)

Holdings (41)

IMMUNOMEDICS INC 11.0%
Value ($000) $183,685 Shares 5,182,983 Est. Cost $13.38 Unrealized
STAA STAAR SURGICAL CO 10.4%
Value ($000) $173,614 Shares 2,821,154 Est. Cost $13.06 Unrealized +212.8%
BMRN BIOMARIN PHARMACEUTICAL INC 10.4%
Value ($000) $173,410 Shares 1,405,950 Est. Cost $80.19 Unrealized +23.9%
INSM INSMED INC 9.9%
Value ($000) $165,303 Shares 6,002,289 Est. Cost $17.16 Unrealized +38.1%
ABIOMED INC 7.1%
Value ($000) $118,928 Shares 492,333 Est. Cost $37.80 Unrealized
FOLD AMICUS THERAPEUTICS INC 6.6%
Value ($000) $110,607 Shares 7,334,714 Est. Cost $7.59 Unrealized +60.5%
UTHR UNITED THERAPEUTICS CORP 5.6%
Value ($000) $92,735 Shares 766,406 Est. Cost $88.73 Unrealized +26.8%
EPIZYME INC 5.3%
Value ($000) $88,550 Shares 5,513,676 Est. Cost $15.12 Unrealized
KARYOPHARM THERAPEUTICS INC 4.8%
Value ($000) $79,916 Shares 4,219,452 Est. Cost $17.42 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 4.6%
Value ($000) $75,851 Shares 1,564,900 Est. Cost $27.34 Unrealized +75.6%
AIMMUNE THERAPEUTICS INC 3.3%
Value ($000) $55,447 Shares 3,318,212 Est. Cost $22.84 Unrealized
ALEXION PHARMACEUTICALS INC 3.0%
Value ($000) $49,905 Shares 444,629 Est. Cost $121.54 Unrealized
MOMENTA PHARMACEUTICALS INC 3.0%
Value ($000) $49,224 Shares 1,479,524 Est. Cost $14.06 Unrealized
VNDA VANDA PHARMACEUTICALS INC 2.8%
Value ($000) $47,093 Shares 4,116,548 Est. Cost $11.21 Unrealized +1.0%
REVANCE THERAPEUTICS INC 2.5%
Value ($000) $41,621 Shares 1,704,372 Est. Cost $21.02 Unrealized
CLOVIS ONCOLOGY INC 1.8%
Value ($000) $29,440 Shares 4,361,411 Est. Cost $48.59 Unrealized
SAGE THERAPEUTICS INC 1.4%
Value ($000) $23,917 Shares 575,200 Est. Cost $48.62 Unrealized
AMAG PHARMACEUTICALS INC 1.4%
Value ($000) $22,641 Shares 2,959,587 Est. Cost $29.07 Unrealized
ALGN ALIGN TECHNOLOGY INC 1.1%
Value ($000) $18,526 Shares 67,505 Est. Cost $114.31 Unrealized +97.0%
PBYI PUMA BIOTECHNOLOGY INC 0.8%
Value ($000) $14,017 Shares 1,343,897 Est. Cost $28.26 Unrealized -63.4%
DICERNA PHARMACEUTICALS INC 0.5%
Value ($000) $8,428 Shares 331,813 Est. Cost $5.39 Unrealized
PRTA PROTHENA CORP PLC 0.5%
Value ($000) $8,065 Shares 771,065 Est. Cost $32.98 Unrealized -66.3%
RIGEL PHARMACEUTICALS INC 0.4%
Value ($000) $6,483 Shares 3,542,551 Est. Cost $3.40 Unrealized
KLDO KALEIDO BIOSCIENCES INC 0.4%
Value ($000) $5,843 Shares 786,400 Est. Cost $13.76 Unrealized -51.3%
CYTK CYTOKINETICS INC 0.2%
Value ($000) $2,915 Shares 123,686 Est. Cost $6.71 Unrealized +179.3%
ZOGENIX INC 0.2%
Value ($000) $2,812 Shares 104,100 Est. Cost $23.14 Unrealized
GOSS GOSSAMER BIO INC 0.2%
Value ($000) $2,655 Shares 204,214 Est. Cost $12.58 Unrealized 0.0%
ATHENEX INC 0.2%
Value ($000) $2,548 Shares 185,200 Est. Cost $13.76 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.1%
Value ($000) $1,893 Shares 127,700 Est. Cost $12.20 Unrealized +24.8%
APREA THERAPEUTICS INC 0.1%
Value ($000) $1,832 Shares 47,234 Est. Cost $38.79 Unrealized
MAGENTA THERAPEUTICS INC 0.1%
Value ($000) $1,461 Shares 194,600 Est. Cost $7.51 Unrealized
ALIMERA SCIENCES INC 0.1%
Value ($000) $1,266 Shares 200,919 Est. Cost $6.30 Unrealized
KEZAR LIFE SCIENCES INC 0.1%
Value ($000) $1,062 Shares 205,086 Est. Cost $5.18 Unrealized
INTRA-CELLULAR THERAPIES INC 0.1%
Value ($000) $960 Shares 37,400 Est. Cost $34.30 Unrealized
RETROPHIN INC 0.1%
Value ($000) $959 Shares 47,000 Est. Cost $14.60 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value ($000) $640 Shares 24,500 Est. Cost $27.01 Unrealized -9.5%
MARINUS PHARMACEUTICALS INC 0.0%
Value ($000) $318 Shares 125,321 Est. Cost $4.17 Unrealized
SUNESIS PHARMACEUTICALS INC 0.0%
Value ($000) $306 Shares 1,162,473 Est. Cost $4.37 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value ($000) $306 Shares 73,500 Est. Cost $7.53 Unrealized -51.5%
IDERA PHARMACEUTICALS INC 0.0%
Value ($000) $138 Shares 77,044 Est. Cost $8.90 Unrealized
MINERVA NEUROSCIENCES INC 0.0%
Value ($000) $131 Shares 36,319 Est. Cost $5.62 Unrealized